Form 4: Xenon Pharmaceuticals Inc. Director Garofalo Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Elizabeth A. Garofalo exercised stock options and sold common shares of Xenon Pharmaceuticals Inc. on March 8, 2024.
Summary
- On March 8, 2024, Elizabeth A. Garofalo, a director of Xenon Pharmaceuticals Inc., executed a stock option to acquire 3,500 common shares at a price of $18.56.
- Simultaneously, Garofalo disposed of 3,500 shares acquired from the option exercise.
- Garofalo also disposed of 1,408 shares to cover tax obligations at $46.16 per share.
- Additionally, Garofalo sold 2,092 shares at $45.69 per share.
- Following these transactions, Garofalo directly owns 0 common shares.
- Garofalo also holds 16,500 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions can be influenced by various factors, including personal financial planning and company performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of transaction: Stock option exercise and share sales. |
| 06/02/2031 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.